Bleeding potential and effectiveness of perioperative ketorolac administration in tonsillectomy: A systemic review and meta-analysis

IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY
Do Hyun Kim , David W. Jang , Se Hwan Hwang
{"title":"Bleeding potential and effectiveness of perioperative ketorolac administration in tonsillectomy: A systemic review and meta-analysis","authors":"Do Hyun Kim ,&nbsp;David W. Jang ,&nbsp;Se Hwan Hwang","doi":"10.1016/j.ijporl.2025.112608","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To investigate the safety and effectiveness of perioperative ketorolac administration in tonsillectomy.</div></div><div><h3>Methods</h3><div>In this analysis, we examined 15 studies encompassing 1249 patients, obtained from the PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases up to June 2025. Among these, 13 studies included only children, whereas 2 studies included only adults. These studies investigated the perioperative administration of ketorolac in comparison with control applications (saline, acetaminophen, or opioids). The outcomes assessed were postoperative pain levels; utilization patterns of analgesic medication in terms of quantity and frequency; and the incidence rates of postoperative nausea, vomiting, and bleeding.</div></div><div><h3>Results</h3><div>Compared to the control group, incidence of primary (on operation day) postoperative bleeding (significant bleeding: odd ratio (OR) = 3.21, 95 % CI [0.43; 24.19], I<sup>2</sup> = 30.7 %/need surgery to control bleeding: OR = 2.71, 95 % CI [0.77; 9.56]; I<sup>2</sup> = 0.0 %) and secondary (after operation day) postoperative bleeding (significant bleeding: OR = 1.46, 95 % CI [0.63; 3.39], I<sup>2</sup> = 27.8 %/need surgery to control bleeding: OR = 2.10, 95 % CI [0.43; 10.21]; I<sup>2</sup> = 0.0 %) were not significantly higher in the ketorolac group. Compared to the control group, the ketorolac group experienced a significant decrease of postoperative nausea and vomiting (OR = 0.61, 95 % CI [0.41; 0.91], I<sup>2</sup> = 42.3 %). In addition, administration of ketorolac demonstrated efficacy in reducing postoperative pain and amount of analgesic drug compared with the control group.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that administration of ketorolac for tonsillectomy did not appear to increase the incidence of postoperative bleeding in children or adults; however, further studies are needed to confirm this finding. Additionally, ketorolac could improve postoperative emesis and early pain control.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"198 ","pages":"Article 112608"},"PeriodicalIF":1.3000,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pediatric otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165587625003969","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To investigate the safety and effectiveness of perioperative ketorolac administration in tonsillectomy.

Methods

In this analysis, we examined 15 studies encompassing 1249 patients, obtained from the PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases up to June 2025. Among these, 13 studies included only children, whereas 2 studies included only adults. These studies investigated the perioperative administration of ketorolac in comparison with control applications (saline, acetaminophen, or opioids). The outcomes assessed were postoperative pain levels; utilization patterns of analgesic medication in terms of quantity and frequency; and the incidence rates of postoperative nausea, vomiting, and bleeding.

Results

Compared to the control group, incidence of primary (on operation day) postoperative bleeding (significant bleeding: odd ratio (OR) = 3.21, 95 % CI [0.43; 24.19], I2 = 30.7 %/need surgery to control bleeding: OR = 2.71, 95 % CI [0.77; 9.56]; I2 = 0.0 %) and secondary (after operation day) postoperative bleeding (significant bleeding: OR = 1.46, 95 % CI [0.63; 3.39], I2 = 27.8 %/need surgery to control bleeding: OR = 2.10, 95 % CI [0.43; 10.21]; I2 = 0.0 %) were not significantly higher in the ketorolac group. Compared to the control group, the ketorolac group experienced a significant decrease of postoperative nausea and vomiting (OR = 0.61, 95 % CI [0.41; 0.91], I2 = 42.3 %). In addition, administration of ketorolac demonstrated efficacy in reducing postoperative pain and amount of analgesic drug compared with the control group.

Conclusion

This study demonstrated that administration of ketorolac for tonsillectomy did not appear to increase the incidence of postoperative bleeding in children or adults; however, further studies are needed to confirm this finding. Additionally, ketorolac could improve postoperative emesis and early pain control.
扁桃体切除术围手术期给予酮咯酸的出血可能性和有效性:一项系统回顾和荟萃分析。
目的:探讨扁桃体切除术围手术期给予酮咯酸的安全性和有效性。方法:在这项分析中,我们检查了15项研究,包括1249名患者,这些研究来自PubMed、SCOPUS、Embase、Web of Science和Cochrane数据库,截止到2025年6月。其中,13项研究仅针对儿童,2项研究仅针对成人。这些研究调查了围手术期使用酮咯酸与对照应用(生理盐水、对乙酰氨基酚或阿片类药物)的比较。评估的结果是术后疼痛水平;镇痛药物使用的数量和频率;以及术后恶心,呕吐和出血的发生率。结果:与对照组比较,术后原发性(手术当日)出血发生率(显著出血:奇数比(OR) = 3.21, 95% CI [0.43;24.19], I2 = 30.7% /需要手术控制出血:OR = 2.71, 95% CI [0.77];9.56);I2 = 0.0%)和术后继发出血(显著出血:OR = 1.46, 95% CI [0.63; 3.39], I2 = 27.8% /需要手术控制出血:OR = 2.10, 95% CI [0.43; 10.21]; I2 = 0.0%)在酮洛酸组中均无显著升高。与对照组相比,酮咯酸组术后恶心呕吐明显减少(OR = 0.61, 95% CI [0.41; 0.91], I2 = 42.3%)。此外,与对照组相比,给予酮咯酸在减轻术后疼痛和镇痛药量方面均有疗效。结论:本研究表明,在儿童或成人扁桃体切除术中给予酮咯酸并不会增加术后出血的发生率;然而,需要进一步的研究来证实这一发现。此外,酮咯酸可改善术后呕吐和早期疼痛控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
6.70%
发文量
276
审稿时长
62 days
期刊介绍: The purpose of the International Journal of Pediatric Otorhinolaryngology is to concentrate and disseminate information concerning prevention, cure and care of otorhinolaryngological disorders in infants and children due to developmental, degenerative, infectious, neoplastic, traumatic, social, psychiatric and economic causes. The Journal provides a medium for clinical and basic contributions in all of the areas of pediatric otorhinolaryngology. This includes medical and surgical otology, bronchoesophagology, laryngology, rhinology, diseases of the head and neck, and disorders of communication, including voice, speech and language disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信